Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno launches Dyno eCap 1™ capsid product, a leading eye AAV gene delivery vector with best-in-class potential.